A widely used model system to investigate cell proliferation is stimulation of serum-arrested cells with growth factors. Recent data suggest that there are two waves of growth factor-dependent signaling events required for a proliferative response. One is an acute burst of signaling, which occurs immediately after growth factor stimulation and lasts for 30 ± 60 min. The other occurs in a dierent time frame (8 ± 12 h post stimulation), and involves activation of cyclin dependent kinases (Cdks). In addition to a general overview of growth factor-dependent signaling, we present our`two wave' hypothesis for how signaling and cell cycle progression are linked. Oncogene (2000) 19, 5558 ± 5567.
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Three steps in growth factor-dependent signaling The first step: binding of growth factor to the transmembrane receptor A recurring theme for growth factor receptors is ligand-induced dimerization of the receptor. There are a variety of ways in which this occurs. Some ligands, such as platelet-derived growth factor (PDGF) are dimeric, and their receptors encode a single ligandbinding domain. As a result two receptors bind to each monomer of the ligand resulting in dimerization of the receptors. The PDGF ligand is a member of a family of cysteine knot-containing proteins, and many other growth factors that share this structural feature appear to interact with their receptors in a comparable fashion (McDonald and Hendrickson, 1993) . Other growth factors are monomeric and manage dimerization of their cognate receptors by a dierent strategy. Members of the ®broblast growth factor (FGF) family have two binding sites for the receptor within a single molecule of FGF. Resolution of the crystal structure and FGF ligand-receptor complex indicated that each receptor molecule also has two binding sites for the ligand (Plotnikov et al., 1999 (Plotnikov et al., , 2000 Stauber et al., 2000) . Hence the ligand-receptor complex consists of two molecules of receptor and two molecules of FGF. An additional feature of the FGF family is that high anity binding of FGF to its receptor requires heparan sulfate proteoglycans, which spatially organize the ligands to functionally associate with the receptor.
These are only two examples of how growth factors dimerize their receptors; a number of reviews cover additional well studied cases (Hubbard, 1999; Ullrich and Schlessinger, 1990) .
The theme of ligand-induced dimerization of receptors is not universal. The insulin receptor is a dimer even before binding of insulin, which is a monomer. In addition, polymerized collagen is a ligand for the discoidin receptor tyrosine kinases, (Shrivastave et al., 1997; Vogel et al., 1997) , and it is not obvious whether this sort of ligand is able to induce dimerization or oligomerization of its receptor. In summary, many although not all receptor tyrosine kinases are dimerized in response to binding of ligand, and there are a variety of mechanisms by which this event proceeds.
The second step: activation of the receptor's kinase activity
Binding of ligand results in an elevation of the receptor's kinase activity. Activation of a kinase involves a recon®guration of various domains, including the activation loop, as well as the orientation of the upper and lower lobes of the kinase (Sicheri and Kuriyan, 1997) . Tyrosine kinase are often phosphorylated in the activation loop, and this event probably contributes to the conformational changes leading to activation of the kinase. For receptor tyrosine kinases, ligand-induced dimerization brings the kinase domains into close proximity and facilitates transphosphorylation at the activation loop tyrosines (Hubbard, 1999; Weiss and Schlessinger, 1998) . Whether ligand binding promotes additional events that contribute to activation of the kinase is still not fully understood.
While the ligand promotes activation of a receptor tyrosine kinase, there are also factors that suppress the receptor's kinase activity. Cells express many types of phosphotyrosine phosphatase (PTPs) that have the potential to functionally repress the receptor's kinase activity. For instance, addition of inhibitors of PTPs leads to a rapid increase in the phosphorylation of receptor tyrosine kinases in the apparent absence of ligand. In addition, growth factors trigger a burst of hydrogen peroxide production, which has the potential to inhibit PTPs. In some cell types inhibition of peroxide production blunts PDGF-dependent tyrosine phosphorylation of the PDGFR (Sundaresan et al., 1995) , whereas in others it does not (Bae et al., 2000) . Finally, there are proteins that prevent activation of receptor tyrosine kinases. Kek-1 is a transmembrane protein that physically interacts with the drosophila EGFR and antagonizes the eect of EGFR (Ghiglione et al., 1999) . Whether functionally similar proteins exists in mammalian systems, as well as what step of the activation mechanism they impact remain open questions. In summary, the balance between positive and negative factors determines the activity of a receptor tyrosine kinase.
The third step: recruitment and activation of signaling enzymes
One of the consequences of tyrosine phosphorylation of the receptor is to enable the receptor to recruit a variety of signaling enzymes Kazlauskas, 1994) . The interaction of signaling enzymes with the activated receptor is dependent on tyrosine phosphorylation of the receptor (i.e. conditional). This interaction is also speci®c, and the speci®city is determined by both the receptor and the signaling enzyme Kazlauskas, 1994) . The amino acid context surrounding the tyrosine phosphorylation site is the receptor's contribution to speci®city, whereas the PTB or SH2 domain of the signaling enzymes has an intrinsic preference for binding partners, and hence makes a contribution to the speci®city of the interaction. There is a long and growing list of proteins that associate with the bPDGFR Kazlauskas, 1994) , and these same signaling enzymes can associate with many other activated receptor tyrosine kinases as well. In this review we will focus on several well-studied examples, and refer the interested reader to other reviews for additional information Kazlauskas, 1994) .
One of the signaling proteins activated in a growth factor-stimulated cell is Ras (Schlessinger, 1993) . Activated Ras functions as a cofactor for a variety of signaling enzymes (Marshall, 1996) . The nucleotide exchange factor, Sos promotes the exchange of GDP for GTP on Ras, which converts Ras to its active state (Figure 1 ). Inactivation of Ras proceeds by a distinct chemical reaction, i.e. hydrolysis of the GTP to GDP, and is promoted by GTP-ase activating proteins called GAPs. Sos is a constitutively active cytoplasmic enzyme, whereas Ras is anchored to the membrane. Consequently, activation of Ras requires translocation of Sos from the cytoplasm to the membrane, which is mediated by adapter proteins. There are several ways by which Ras can be activated in growth factorstimulated cells, and they all appear to involve a change in the subcellular localization of the Grb2/Sos complex. Grb2 is an SH3-SH2-SH3 adapter protein that mediates binding of Sos to activated receptors. The Grb2/Sos complex is constitutive, and in resting cells, is primarily cytoplasmic. Tyrosine phosphorylation of the receptor enables the SH2 domain of Grb2 to stably associate with receptor tyrosine kinase receptors. This relocalizes Sos to the membrane, the cellular compartment in which its substrate, Ras resides (Figure 2 ). Alternative scenarios include association of the Grb2/Sos complex with other adapter proteins such as Shc. Many growth factors induce tyrosine phosphorylation of Shc, leading to its association with Grb2/Sos. This trimeric complex can relocate to the membrane via Shc's SH2 or PTB/PH domains. The functional consequence of these changes is the same as when Grb2/Sos associates with a tyrosine phosphorylated growth factor receptor: Sos gains access to Ras and activates it.
Phosphoinositide 3 kinase (PI3K) is one of the SH2 domain-containing signaling enzymes that are activated in growth factor-stimulated cells. The p85 subunit of PI3K contains a number of domains, and it is via the SH2 domains that p85, and its tightly associated p110 catalytic subunit, are recruited to activated receptors. Unlike the Grb2/Sos complex, localizing the PI3K holoenzyme to the membrane by it association with the PDGFR is not sucient to activate the enzyme (Klinghoer et al., 1996) . Ras must be activated, which directly binds to the catalytic subunit of PI3K (Rodriguez-Viciana et al., 1994 , 1996 , and provides the necessary second input for activation in growth factor-stimulated cells (Figure 3 ). PI3K is being increasingly appreciated as a family of enzymes instead of a single entity, and the individual members of the PI3K family may have unique functions in promoting growth factor-dependent responses (Fruman et al., 1998; Roche et al., 1998) .
Tyrosine phosphorylation of signaling enzymes is an additional component of their activation in growth factor-stimulated cells. While some of these proteins are direct substrates of the receptor, they may also be phosphorylated by the kinases activated by the receptor. For instance, Src family kinases (SFKs) are activated in PDGF-stimulated cells (Gelderloos et al., 1998; Hooshmand-Rad et al., 1998; Mori et al., 1993) , and they phosphorylate many proteins, including phospholipase C g (PLCg) (Liao et al., 1993) . PDGFdependent tyrosine phosphorylation of PLCg is dramatically compromised in cells expressing PDGFRs that fail to activate SFKs (DeMali and Schlesinger et al., 1999) . In contrast, comparable PDGF-dependent tyrosine phosphorylation of PLCg was observed in cells that lacked SFKs versus cells in which Src had been reexpressed . Tyrosine phosphorylation of signaling enzymes may proceed via more than one PDGF-activated kinase.
Converting enzymology into a cellular response
In comparison to the ®rst three steps of growth factordependent signaling, our understanding of how these steps culminate in cellular responses is very limited. The eventual consequence of exposing cells to growth Figure 1 Activation of Ras. Activation of Ras is catalyzed by the nucleotide exchange factor Sos, which promotes the release of GDP. Although Ras has intrinsic GTPase activity, the hydrolysis of GTP to GDP is enhanced by GAP, and this event converts Ras back to its inactive state factors such as PDGF can be cell movement, proliferation, dierentiation or protection from death. How the cell selects amongst these possible responses, and the alteration in the signaling cascades necessary to mediate the appropriate response remains poorly understood. However, signi®cant progress has been made in identifying which of the many signaling enzymes are required for cellular responses such as mitogenesis. Using a variety of approaches, most investigators conclude that PI3K and to a lesser extent PLCg are contributing to PDGF-dependent mitogenesis Kazlauskas, 1994; Roche et al., 1994 Roche et al., , 1996 . Furthermore, these two enzymes appear to be functionally redundant, as PDGFdependent DNA synthesis can be rescued in a mitogenically incompetent receptor mutant when either the PI3K or PLCg/PKC pathway is activated (Valius and Kazlauskas, 1993) . Such ®ndings suggest the existence of a common mitogenic signaling cascade that can be accessed by various signaling enzymes. This issue will be further addressed below.
Growth factors are not the only extracellular cue needed for cell proliferation

Integrins
Integrins are a family of cell surface receptors consisting of heterodimers between a and b subunits that mediate attachment of cells to extracellular matrix (ECM) proteins such as ®bronectin and collagen (Clark and Brugge, 1995; Schwartz and Ingber, 1994) . The intracellular domains of integrin molecules not only physically link the plasma membrane to the cytoskeleton, but also initiate signaling cascades. Evidence that integrins synergize with growth factors to drive a mitogenic response includes the observations that integrins and activated receptor tyrosine kinase coprecipitate (Schneller et al., 1997) . In addition, the nature of the ECM onto which cells are plated (and hence the types of integrins that are engaged) can enhance or diminish the mitogenic potency of growth factors Schneller et al., 1997) . Finally, compromising the contribution of integrins by suspending a population of adherent cells alters some of the signaling pathways triggered by growth factors, and prevents cell cycle progression (Assoian, 1997; Clark and Brugge, 1995; Schwartz and Ingber, 1994) . The growth factor promotes tyrosine phosphorylation of Shc and hence it association with Grb2 via the SH2 domain of Grb2. The resulting trimer is recruited to the membrane in one of two ways. The SH2 domain of Shc mediates binding to a tyrosine phosphorylated receptor (c). Alternatively, the PTB/PH domain of Shc interacts with lipids in the membrane and hence translocates the Shc/Grb2/Sos complex to the membrane. These membrane lipids include products of PI3K, which is activated in response to growth factor stimulation. The three recruitment scenarios are not mutually exclusive, and may be occurring simultaneously in growth factor-stimulated cells. As noted in Figure 1 , the functional consequence of recruitment of Sos to the membrane is activation of Ras Figure 3 Activation of PI3K in PDGF-stimulated cells. Two events are required for activation of PI3K in response to PDGF. One is translocation of PI3K from the cytosol to the membrane. Autophosphorylation of the receptor's kinase insert creates binding sites for PI3K, and the SH2 domains of the p85 subunit of PI3K stably associate with the receptor. The second event is accumulation of activated Ras, which is described in Figures 1  and 2 . Active PI3K phosphorylates PI-4-P and PI-4,5-P2 to generate PI-3,4-P2 and PI-3,4,5-P3, respectively, which are potent second messengers that engage a variety of signaling cascades. The ®gure depicts the complex that results from these events Thus the combined inputs of integrins and growth factors are required for cell cycle progression.
Cell shape
Cell cycle progression is also controlled by cell shape and cytoskeletal tension (Huang and Ingber, 1999) . Under conditions where the growth factor and total cell-ECM contact is kept constant, cell shape determines whether the cells do or do not move into S phase (Chen et al., 1997; Huang et al., 1998) . These studies showed that if cells were prevented from spreading, they failed to make the G1/S transition, despite engagement of integrins and the presence of growth factors. The following types of observations support the idea that cytoskeletal tension is also a regulator of cell cycle progression. Cell proliferation within a tissue is localized to regions where the ECM of the basement membrane is thinner than the surrounding regions, and the change in ECM content alters the tensional force on cells (Chen et al., 1997; Folkman and Moscona, 1978; Huang et al., 1998; Ingber, 1990) . In addition, pharmacological disruption of the cytoskeleton (and hence the tractional force) prevents cells from moving into S phase. Finally, activation of Rho A, a small GTPase protein that modulates the integrity of the cytoskeleton, promotes degradation of p27 Kip1 and eliminates the anchorage requirement for S phase entry Schwartz et al., 1996) . These ®ndings demonstrate that cell proliferation is not only regulated by growth factors and the ECM. The shape of the cell and cytoskeletal tension are also important variables and p27
Kip1 is at least one of the points at which they interface with the cell cycle program. The cells shape and tractional force variables may be particularly relevant to in vivo settings as compared with tissue culture systems that are usually used to study regulation of cell proliferation (Huang and Ingber, 1999) .
The cell cycle
The G0 to S interval is the only portion of the cell cycle that is regulated by growth factors When plated at low cell density in serum-containing medium, cultured cells move through four phases of the cell cycle: G1, S, G2 and M (Figure 4) . Each of these phases is regulated by the coordinated action of kinases and proteases (King et al., 1996; Kirschner, 1992) . When deprived of serum, cells continue to cycle until they complete mitosis, whereupon they exit into the G0 state (Pardee, 1974 (Pardee, , 1989 . These cells can be reintroduced into the cell cycle by the re-addition of serum or puri®ed growth factor. The mitogen must be present until the R point, which is several hours prior to the transition between G1 and S (Pardee, 1989; Planas-Silva and Weinberg, 1997) . Thus in serumdeprived cells, all of the growth factor-stimulated events that are necessary for completion of one round of the cell cycle occur before the R point (Figure 4) . Furthermore, growth factors are not needed at later times to complete the other stages of the cell cycle. Figure 5 outlines the cell cycle events that constitute the G1 cell cycle program. Phosphorylation of the retinoblastoma (Rb) protein is the current molecular de®nition of the R point (Planas-Silva and Weinberg, 1997) . At least two classes of G1 cyclin-dependent kinases (Cdks) collaborate to fully phosphorylate Rb, which results in the release of the E2F family of transcription factors (Sherr, 1996) . This class of transcription factors initiates subsequent events necessary for transition through the other phase of the cell cycle, even in the absence of serum. Consequently, the mitogenic side of growth factors is intrinsic to their ability to promote phosphorylation of Rb.
Elements of the cell cycle program that are regulated by signaling enzymes
Growth factors promote phosphorylation of Rb by regulating the activity of the G1 Cdks. This involves promoting the synthesis and stability of cyclin subunits, as well as decreasing the levels of Cdk inhibitors (Figure 5b ). For instance, growth factordependent activation of the Ras/Erk pathway increases cyclin D1 mRNA (Aktas et al., 1997; Albanese et al., 1995; Cheng et al., 1998; Kerkho and Rapp, 1997; Lavoie et al., 1996; Peeper et al., 1997; Winston et al., 1996) . Furthermore, the PI3K/Akt pathway stabilizes the cyclin D1 proteins. At least in some cell types, activation of Akt inhibits glycogen synthase kinase 3 b (GSK3b)-dependent phosphorylation of cyclin D1 and thereby prevents its degradation via the proteasomal pathway (Cross et al., 1995; Diehl et al., 1997 Diehl et al., , 1998 Rimerman et al., 2000) . Others have also implicated P13K/Akt in cyclin D1 accumulation, although the mechanism of action does not appear to be in stabilization of the cyclin D1 protein, and appears to involve transcriptional activation of cyclin D1 (Gille and Downward, 1999) . Accumulation of cyclin D1 results in the assembly of cyclin D1/Cdk4,6 complexes . Growth factor-dependent elimination of Cdk inhibitors such as p27
Kip1 proceeds through Figure 4 Only a small portion of the cell cycle is regulated by growth factors. Cells that have been deprived of serum or growth factors exit the cell cycle and enter into the G0 state. Growth factors promote exit from G0, and cells will commit to one round of the cell cycle if growth factors are present up to the R point. An important component of the R point is phosphorylation of Rb, which is further outlined in Figure 5 . Once past the R point, most cells will continue through the other stages of the cell cycle, even if the growth factor is removed from the culture medium a P13K dependent pathway and is essential for transition through G1 and into S phase (Agrawal et al., 1996; Gille and Downward, 1999, Takuwa and Takuwa, 1997) . Recent studies indicate that Akt acts downstream of P13K to phosphorylate members of the forkhead family of transcription factors such as AFX/ FKHR (Brunet et al., 1999; Guo et al., 1999 , Kops et al., 1999 Rena et al., 1999; Tang et al., 1999) . When phosphorylated these transcription factors move out of the nucleus and thereby ceases driving transcription of p27 Kip1 (Medema et al., 2000) . Hence growth factors promote Cdk activity by increasing levels of cyclins and decreasing the levels of Cdk inhibitors.
Active cyclin D1/Cdk4,6 partially phosphorylates Rb, which begins to release the E2F family members (Figure 5a ). Free E2F promotes the transcription and Kip1 and p21 Cip1 (not shown) promote assembly of the cyclin D/Cdk4,6 complex. p27 Kip1 inhibits the kinase activity of both of the cyclin/Cdk complexes, and appears to be more potent towards cyclin E/Cdk2. There are at least three ways by which p27
Kip1 is neutralized. Growth factors suppress the synthesis of p27 Kip1 protein; cyclin E/Cdk2 phosphorylates p27 Kip1 and targets it for degradation; cyclin D/Cdk4,6 sequester p27 Kip1 . GSK3 is glycogen synthase kinase 3 b; AFX/FKHR is the forkhead transcription factor consequent accumulation of a second cyclin, cyclin E, which couples with the Cdk2 kinases. The appearance of cyclin E/Cdk2 has at least three functional consequences (Figure 5b ) Firstly, it acts in collaboration with cyclin D1/Cdk4,6 to titrate p27 Kip1 levels. Secondly, cyclin E/Cdk2 phosphorylates p27 Kip1 and hence targets it for ubiquitination and degradation via the proteasome (Pagano et al., 1995; Vlach et al., 1997) . Thirdly, cyclin E/Cdk2 further phosphorylates Rb, which fully activates the E2F family (Figure 5a ).
The role of p27 Kip1 and a second Cdk inhibitor, p21
Cip1
, has become more complicated with the appreciation of an additional function for these proteins. They not only block Cdk activity, but p27 Kip1 and p21
Cip1 are also instrumental in the assembly of the cyclin D1/Cdk complexes (Cheng et al., 1999; LaBaer et al., 1997) (Figure 5 ). Furthermore, p21
Cip1 and p27 Kip1 are components of the active cyclin D1/Cdk4,6 enzyme (Cheng et al., 1999) . Finally, there appears to be a dierence between cyclin D1/ Cdk4,6 and cyclin E/Cdk2 in the way they are regulated by p27 Kip1 . In contrast to the readily detectable kinase activity of the cyclin D1/Cdk4,6/ p27
Kip1 complex, when p27 Kip1 joins the cyclin E/Cdk2 complex, it extinguishes kinase activity (Hengst and Reed, 1998; Sherr and Roberts, 1999) . Thus the Cdk inhibitors promote activation of cyclin D1/Cdk4, 6, and inhibit the activity of cyclin E/Cdk2. Further studies will be required to resolve the apparent paradox regarding how the Cdks both promote and inhibit (Toyoshima and Hunter, 1994) cyclin D1/ Cdk4,6 activity.
In summary, activation of the Ras/Erk or P13K/Akt pathways results in an increase in cyclin D1 mRNA, and some investigators ®nd that the P13K/Akt pathway stabilizes the cyclin D1 protein. In addition, growth factors suppress p27
Kip1 levels, in a pathway that also involves PI3K. Thus cyclin D1 and p27
Kip1 are two points in cell cycle program at which growth factor-stimulated signaling makes input. Since full phosphorylation of Rb, i.e. passing the R point, requires the coordinated input of several distinct components of the cell cycle program, there may be additional points of the cell cycle program at which growth factor-dependent signaling make other essential contributions.
Most of the well-studied growth factor-initiated signaling events occur many hours before the cell cycle program
Growth factor-stimulated signaling is transient
In acutely-stimulated cells there are two themes to the signaling events: phosphorylation/dephosphorylation and changes in the subcellular location. For instance, tyrosine phosphorylation of the PDGFR at the appropriate tyrosine residues enables stable association with P13K (Claesson-Welsh, 1994; Kazlauskas, 1994) . While this relocates P13K from the cytoplasm to a juxtamembrane location, the location of its lipid substrate, accumulation of active Ras is also needed for activation of PI3K (Klinghoer et al., 1996; Rodriguez-Viciana et al., 1994 , 1996 (Figure 3 ). P13K generates second messengers (PI-3,4-P2 and PI-3,4,5-P3), which are the activators for downstream signaling enzymes such as Akt and PKC family members (Fruman et al., 1998; Toker and Cantley, 1997) . These ser/thr kinases are some of the enzymes capable of relaying the mitogenic signal along a cascade that appears to be part of the network that integrates signals, which emanate from integrins and the sensors of cell shape and cytoskeletal integrity.
While the exact nature of this overall signaling network is far from understood, it is clear that the initial phase of growth factor-stimulated signaling events does not persist much longer than 60 min. For instance, PI3K products accumulate within minutes of PDGF-stimulation and then return to near basal levels by 30 min (Auger et al., 1989; Hawkins et al., 1992; Jones et al., 1999 ). There appears to be a variety of reasons why signaling subsides, one of which relates to the half-life of the growth factor receptor. One of the proteins that is phosphorylated in response to growth factors is c-Cb1, a protein that promotes internalization and/or degradation of growth factor receptors (Lupher et al., 1998) . Enzymes such as PTEN, a phosphatase capable of dephosphorylating and hence metabolizing the P13K lipid products, may also contribute to the decline of cellular P13K lipid products (Cantley and Neel, 1999) . Other well-characterized mechanisms to extinguish signaling include the rapid expression of new genes that counteract the signaling enzymes. MKP-1 is a phosphatase that dephosphorylates and hence inactivates Erk family members (Sun et al., 1993) . In resting cells MKP-1 levels are low and then rise quickly following mitogenic stimulation.
In summary, growth factors trigger a rapid burst of signaling events that subsides even in the continuous presence of growth factor. Receptor internalization and degradation, as well as the appearance of enzymes, which antagonize the signaling enzymes, are some of the ways in which the cell silences the growth factorinitiated signaling cascade.
How do growth factor-stimulated signaling events engage the cell cycle program?
If the ®rst wave of growth factor-dependent signaling is complete within 60 min, then what triggers the cell cycle program, which begins roughly 9 h after exposure to PDGF? Since the early signaling events induce the expression of many new genes, including those that are involved in cell proliferation, perhaps it is the products of these genes that are responsible for engaging the cell cycle program. If this were indeed the case, then exposure to growth factor for 1 ± 2 h which is sucient to induce the immediate early genes, would also be sucient to drive cells into S phase. However, ®broblasts require 8 ± 10 h of continuous exposure to growth factor to get past the R point (Pardee, 1989; Stiles et al., 1979a,c) . Hence the early burst of signaling is insucient for cell cycle progression, and there must be additional inputs that the growth factor makes at latter time points. Insight into this long-standing question has come from a number of labs demonstrating that there are requirements for signaling enzymes and/or signaling events well beyond the well-studied early burst of signaling.
Growth factor-stimulated signaling beyond the ®rst 60 min
Microinjection studies indicate that signaling enzymes are needed well beyond the first 60 min One approach to investigate the importance of a signaling enzyme for growth factor-dependent mitogenesis is to eliminate it by microinjection of a neutralizing antibody directed against the signaling enzyme, and assay the eect on S phase entry. The Stacey lab used this approach, and learned that activated Ras is required for entry into S phase (Mulcahy et al., 1985) . These studies were preformed by pre-injecting cells with the antibody, and then stimulating with the mitogen. By injecting the antibody after exposing cells to the growth factor it has been possible to assess when the signaling enzyme is contributing to mitogenic signaling. Blocking Ras, SHP-2 or PI3K hours after the initial wave of growth factor-dependent signaling had occurred prevented growth factor-dependent entry into S phase (Bennett et al., 1996; Dobrowolski et al., 1994; Roche et al., 1994 Roche et al., , 1996 Rose et al., 1998) . These studies strongly suggested that signaling enzymes are important for mitogenic signaling at times beyond the initial burst of signaling.
Two waves of signaling in cells treated continuously with growth factors
To directly investigate the idea that signaling is occurring at later time points, a number of investigators began to monitor signaling events in cells that had been treated with growth factors for longer times. For instance, several groups have reported biphasic activation of Ras in serum stimulated NIH3T3 cells (Gille and Downward, 1999; Taylor and Shalloway, 1996) . The level of active Ras peaks within 10 or 30 min, recedes, and then peaks again 2 ± 6 or 2 ± 4 h later. Similarly, PDGF triggers two waves of PI3K and PKC activity in HepG2 cells, an early and then a late phase; the late phase being 3 ± 7 h after the addition of growth factor (Balciunaite et al., 2000; Jones et al., 1999 ). These studies demonstrate that there are two waves of activity for a number of signaling systems and raise a number of interesting questions.
For instance, how are these two waves of activity regulated? The ®rst wave of activity has been studied at length, as it is the one observed in acutely stimulated cells. As outlined in the sections above, there is a wealth of information regarding the mechanism by which signaling enzymes such as Ras and PI3K are activated in acutely stimulated cells. In contrast, virtually nothing is known regarding the molecular events by which the second wave of activity appears. Whether the mechanisms by which the signaling enzymes are activated during the ®rst and second wave of signaling are comparable await further investigation.
The second wave of signaling is required for cell proliferation
An additional question that arises from the observation that there are two waves of enzymatic activity is the relative contribution of each wave to growth factordriven mitogenesis. The second wave of signaling is required for S phase entry, at least in the case of Ras and PI3K, since injecting neutralizing antibodies directed against these proteins blocked cell cycle progression. Additional approaches have also found that the second wave of PI3K, PKC and Ras activity is essential for cells to respond mitogenically to growth factors (Balciunaite et al., 2000; Dobrowolski et al., 1994; Jones et al., 1999; Takuwa and Takuwa, 1997) .
For some of the signaling enzymes the ®rst and second waves of signaling make unequal contributions to the mitogenic response. In the case of PI3K, and certain PKC family members, only the second wave of activity was required for PDGF-dependent entry into S phase (Balciunaite et al., 2000; Jones et al., 1999) . The addition of pharmacological inhibitors at times corresponding to the second wave of activity attenuated PDGF-dependent DNA synthesis. The inhibitors had no eect if they were used to block only the ®rst wave of PI3K or PKC activity. Similarly, adding synthetic PI3K lipid products or diacylglycerol (DAG), an activator of certain PKC family members, rescued PDGF-dependent DNA synthesis, but only when they were added at times corresponding to the second wave of activity. Adding the PI3K lipid products or DAG simultaneously with PDGF failed to promote PDGFdependent DNA synthesis in this system. Hence, although PI3K and PKCs are activated during the ®rst wave of PDGF-induced signaling, their activation at this time is dispensable for the DNA synthesis response. It is likely that they are contributing to other PDGF-dependent cellular responses such as chemotaxis and survival (Kundra et al., 1994; Rosenkranz and Kazlauskas, 1999; Yao and Cooper, 1995) .
The`two wave' hypothesis for how signaling and cell cycle progression are linked Growth factor-dependent signaling is not needed continuously during the interval between G0 and the R point Because the initial wave of signaling occurs so much in advance (7 h) of even the ®rst element of the cell cycle program, these early signaling events do not appear to be directly responsible for engaging components of the cell cycle program. In contrast, the second wave of signaling appears to overlap with the cell cycle program, and hence may be directly triggering the cell cycle program. This hypothesis has been dicult to test because the second wave of signaling requires prolonged exposure to PDGF, which probably triggers events other than those required for cell cycle progression. We have recently employed a discontinuous stimulation assay (Figure 6 ) to evaluate the possibility that a late phase of signaling is responsible for engaging the cell cycle program (Jones and .
Two 30 min pulses of PDGF are sucient to drive NIH3T3 cells into S phase and through the rest of the cell cycle. Furthermore, the kinetics of S phase entry as well as events of the cell cycle program proceeded comparably in cells treated continuously or discontinuously with PDGF. The ®rst pulse de®ned the start of the experiment, and the ideal time for the second pulse was 8 h. Importantly, the ®rst pulse was insucient to initiate the cell cycle program, whereas that second pulse of growth factor rapidly engaged the cell cycle program, i.e. cyclin D1 protein was detectably elevated within 1 h of the second pulse. Hence the early burst of signaling made the cells able to engage the cell cycle program, which was triggered by the second pulse of PDGF. As illustrated in Figure 7 , we are proposing the terms early G1 (G1 E ), and late G1 (G1 L ) for these portions of G1.
Different sets of signaling enzymes mediate progression through G1 E and G1 L The subdivision of the G0 to S interval is also supported by the ®nding that dierent sets of signaling enzymes mediate transition through G1 E and G1 L (Jones and . Of the many signaling events triggered by the ®rst pulse of PDGF, activation of MEK and elevation of c-Myc were sucient for transition through G1 E . In contrast, synthetic PI3K lipid products failed to drive cells through G1 E , but were sucient for transition through G1 L . These ®ndings indicate that traversing the two segments of the G0 to S interval requires non-identical sets of signaling enzymes. Finally, transition through G1 E is a prerequisite for engaging the cell cycle program, which is the consequence of subsequent exposure to growth factor.
A common signaling cascade is used by many mitogens
Many agents are mitogenic, and while they interact with speci®c and unique cell surface receptors, it is possible that they eventually engage a common cascade to promote cell cycle progression. This idea has been investigated with the discontinuous stimulation assay described above. Six mitogens were tested for their ability to substitute for PDGF during the ®rst or second pulse, i.e. to drive cells through G1 E or G1 L (Jones and . Four of the six agents (fetal bovine serum [FBS] , FGF, PDGF and lysophosphatidic acid [LPA]) were completely interchangeable. Any of the four agents given at the ®rst pulse, followed by any one of the four in the second pulse drove cells into S phase. These ®ndings imply that there is a common signaling cascade that can be accessed by a variety of receptor tyrosine kinases, as well as G protein coupled receptors.
Unlike the four mitogens described above, EGF and insulin failed to drive cells through G1 E . However, these agents were biologically active, as EGF or insulin promoted progression through G1 L . Cells that had been brought through G1 E by a pulse of FBS, bFGF, LPA or PDGF were driven into S phase when EGF or insulin were used for the second pulse. Hence the cells have receptors for EGF and insulin, and these receptors access the necessary events to engage the cell cycle program and propel the cells through G1 L and into S phase. The failure of EGF and insulin to promote transition through G1 E could be because a 30 min pulse of these two growth factors triggers a much less robust activation of Erk and elevation of cMyc, as compared with the four agents that drive cells through G1 E . These ®ndings indicate that there is a common signaling pathway that is utilized by many dierent agents. Furthermore, we predict that any agent capable of activating Erk and elevating c-Myc during the ®rst wave of signaling, followed by an elevation of PI3K products 8 h later will be sucient to drive NIH3T3 cells into S phase.
Several lines of evidence indicate that the signaling pathways discussed above are not the only ones that are capable of engaging the mitogenic cascade. Cells that are nullizygous for c-myc are viable, although they proliferate more slowly than control cells (Mateyak et al., 1997) . Similarly, DAG is as eective as PI3K lipid products in rescuing PDGF-dependent DNA synthesis when added to cells at times that appear to correspond to G1 L (Balciunaite et al., 2000 , Jones et al., 1999 . Hence it is likely that there will be additional enzymes identi®ed that are capable of accessing this common mitogenic cascade.
Revisiting competence and progression
Using subsaturating concentrations of growth factors, Pledger, Stiles, Antoniades, and Sher demonstrated that in Balb/c 3T3s cell cycle progression required the input of two dierent types of factors (Pledger et al., 1977 (Pledger et al., , 1978 Stiles et al., 1979b) . Growth factors such as PDGF or FGF made the cells competent, but did not drive them into S phase. A second class of growth Figure 6 The discontinuous stimulation assay. Serum-arrested NIH3T3 cells were pulsed with PDGF for 30 min, the cells were then acid washed and placed into medium containing 0.1% FBS. 7.5 h later PDGF and [ 3 H]thymidine were added and the cells were harvested at the 18 h time point. S phase, as measured by an increase in the incorporation of [ 3 H]thymidine is between 12 and 26 h in these cells Figure 7 The two-wave hypothesis for how signaling and cell cycle progression are linked. Exposure of quiescent (G0) cells to growth factors initiates many signaling events. Of these, activation of Erk and elevation of c-Myc are sucient to drive cells out of G0 and through the early portion of G1 (G1 E ). Further progression through G1 requires a second input of growth factor. The timing of this requirement overlaps with the second wave of signaling, and initiates the cell cycle program. This occurs in the late phase of G1, and is termed G1 L . PI3K is one of the signaling enzymes that are activated at this later time and capable of engaging the cell cycle program. As outlined in Figure 5 , the cell cycle program results in phosphorylation of Rb, transition past the R point and commitment to one round of the cell cycle. At least some of the events that occur in G1 L have been well de®ned, i.e. the cell cycle program. In contrast, the molecular events that are necessary for transition through G1 E are just beginning to be identi®ed factors was required for progression of the competent cell into S phase. Once competent, the cells remained in this state for many hours, and such a cell entered S phase 12 ± 14 h after the addition of a progression factor (Pardee, 1989) . There are several dierences between the competence/progression system and the discontinuous stimulation assay. Firstly, saturating concentrations of growth factor were used in the discontinuous stimulation assay. Under these conditions, PDGF alone is fully capable of driving the NIH3T3 cells into S phase. Secondly, cells that have received the ®rst pulse of PDGF and have completed G1 E have a relatively narrow window (less than 4 h) during which they must receive the second pulse of PDGF in order to continue through G1. Finally, cells enter S phase 4 ± 6 h after the second pulse of PDGF. We speculate that competence is a subset of those events that drive cells through G1 E and that a progression factor is required for completion of G1 E and progression through G1 L . If this interpretation is correct, the availability of these two systems will help to further de®ne the events that must take place in order for a cell to exit G0, enter G1 E and approach G1 L .
Summary
There are three central ideas contained within this review. Firstly, growth factor-stimulated signaling is not restricted to a 30 ± 60 min window, but occurs at much later time as well. Secondly, the second wave of signaling overlaps temporally with the cell cycle program and may be directly responsible for engaging it. Thirdly, the G1 to S interval appears to encompass two distinct phases of the cell cycle, during which the coordinated activation of distinct sets of signaling enzymes drive cell cycle progression. Each of these concepts is likely to initiate new investigation and hence provide additional insight into the fundamental question of how growth factors drive cell proliferation.
